Nirvana Life Sciences Inc. (CSE:NIRV)
0.0350
-0.0150 (-30.00%)
Feb 12, 2025, 9:04 AM EST
Nirvana Life Sciences Statistics
Total Valuation
CSE:NIRV has a market cap or net worth of CAD 1.69 million. The enterprise value is 1.75 million.
Market Cap | 1.69M |
Enterprise Value | 1.75M |
Important Dates
The next estimated earnings date is Thursday, April 3, 2025.
Earnings Date | Apr 3, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
CSE:NIRV has 48.23 million shares outstanding. The number of shares has increased by 18.01% in one year.
Current Share Class | n/a |
Shares Outstanding | 48.23M |
Shares Change (YoY) | +18.01% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 18.09% |
Owned by Institutions (%) | n/a |
Float | 35.93M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -3.81 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.02
Current Ratio | 0.02 |
Quick Ratio | 0.02 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -686.51 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -221.54% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | 42.78% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -22.22% in the last 52 weeks. The beta is 0.76, so CSE:NIRV's price volatility has been lower than the market average.
Beta (5Y) | 0.76 |
52-Week Price Change | -22.22% |
50-Day Moving Average | 0.05 |
200-Day Moving Average | 0.05 |
Relative Strength Index (RSI) | 12.34 |
Average Volume (20 Days) | 1,535 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -456,530 |
Pretax Income | -460,621 |
Net Income | -459,518 |
EBITDA | -474,881 |
EBIT | -456,530 |
Earnings Per Share (EPS) | -0.01 |
Balance Sheet
The company has 619 in cash and 69,152 in debt, giving a net cash position of -68,533 or -0.00 per share.
Cash & Cash Equivalents | 619 |
Total Debt | 69,152 |
Net Cash | -68,533 |
Net Cash Per Share | -0.00 |
Equity (Book Value) | -1.24M |
Book Value Per Share | -0.03 |
Working Capital | -1.24M |
Cash Flow
Operating Cash Flow | -44,106 |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
CSE:NIRV does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -18.01% |
Shareholder Yield | -18.01% |
Earnings Yield | -27.22% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |